RxDoctor Payments Data

Ryan Kuta, DO

Pain Medicine · Naperville, ILNPI 1851882278

Payments from drug & device makers

What this record shows

This record is dominated by grants: $95,053 of the $114,055 with a category attached, or 83.3%. 24 manufacturers reported payments, led by Abbott at 52.3% of the total. Reporting peaked in 2022 at $98,848 and has fallen 96.4% since, to $3,588 in 2025. Among pain medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$114,055in general payments, 2019–2025

Across 310 payments — averaging $367.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$60K
  • Boston Scientific$28K
  • Medtronic$20K
  • Nevro Corp.$2K
  • Saluda Medical Americas, Inc.$1K
  • Nalu Medical, Inc.$646
  • plus $3K from 18 others

What the payments were for

  • Grants$95,05383%
  • Travel & lodging$5,9785%
  • Food & beverage$13,02511%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,055 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$237,853
Medicare patients
343
Services billed
6,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl20$19,324
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen199$3,603
Oxycodone Hcl58$966
Gabapentin106$850
Tizanidine Hcl86$818
Pregabalin50$647
Cyclobenzaprine Hcl57$518
Tramadol Hcl84$416
Methylprednisolone56$343
Celecoxib16$322
Meloxicam82$187
Duloxetine Hcl14$152
Diclofenac Sodium16$143
Methocarbamol13$55

Paid to pharmacies, not to this prescriber.

Other pain medicine in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →